On 12/19/23, Avid Bioservices Inc (NASDAQ: CDMO) stock enjoyed a major increase of 15.4%, closing at $7.05. Moreover, this advance was accompanied by unusually high trading volume at 159% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 39.9% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, CDMO is expected to be a modest Value Eraser.
Avid Bioservices has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Avid Bioservices has a poor Appreciation Score of 16 and a very low Power Rating of 0, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment